Quality Indicator 2022［医療の質］を測り改善する

出版社： インターメディカ
著者：
発行日： 2023-02-20
分野： 医学一般  >  病院管理学
ISBN： 9784899964575
電子書籍版： 2023-02-20 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：約3営業日

3,300 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

3,300 円(税込)

購入する

商品紹介

18年にわたるQI活動の基盤は病院・管理者主導から現場主導へシフト。
次世代の医療の質改善活動へ移行し始めた聖路加国際病院の試み、そしてこれから。
本書は、QIの測定・公表の先駆者たる聖路加国際病院における2004年から2021年までの18年間にわたるQIの経年変化、その間に行われた改善の試みを記した書籍の最新版です。
「医療の質」改善を目指す病院にとって手引きとなる一冊です。
病院・医療法人経営者・管理者など、病院経営・管理に携わる方々に必読の書!!

目次

  • 第1章　 QIとそしてこれから。現場からみる医療の質改善
    ―Quality improvement 2.0の時代に―
    第2章　 JCI・マグネット認証における医療の質評価
    第3章　 病院全体
    第4章　 患者満足
    第5章　 報告・記録
    第6章　 看護
    第7章　 検査・薬剤
    第8章　 手術・処置
    第9章　 生活習慣
    第10章　脳・神経
    第11章　心血管
    第12章　感染管理

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 QIとそしてこれから。現場からみる医療の質改善 - Quality improvement 2. 0の時代に -

P.25 掲載の参考文献
1) 福井次矢, 嶋田元監修 : Quality Indicator 2020 [医療の質] を測り改善する 聖路加国際病院の先端的試み. インターメディカ, 2020.
 
2) 厚生労働省 : 医療の質の評価・公表等推進事業
 
3) 厚生労働省 : 厚生労働省補助事業「医療の質向上のための体制整備事業」 https://jq-qiconf.jcqhc.or.jp/ (2022.10.12 available)
 

第2章 JCI・マグネット認証における医療の質評価

P.38 掲載の参考文献
1) Nuffield Council on Bioethics : Public health : ethical issues. Nuffield Council on Bioethics, 2007.
 

第3章 病院全体

P.44 掲載の参考文献
1) 上原鳴夫, 飯塚悦功, 他 : 医療の質マネジメントシステム-医療機関におけるISO 9001の活用 (Management System ISO SERIES). 日本規格協会, 2003.
 
2) 井部俊子, 中西睦子監修 : 看護管理学習テキスト 第2版 看護経営・経済論. 日本看護協会出版会, 2011.
 
3) EB NURSING編集委員・同編集部 : 看護データバンク-医療・看護の今とコトバがわかる. EB Nursing Vol.10 増刊1号. 中山書店, 2010.
 
4) 厚生統計協会編 : 厚生の指標 増刊 国民衛生の動向 2011/2012. 厚生統計協会, 2011.
 
5) 令和3年 病院運営実態分析調査の概要 (令和3年6月調査) : 一般社団法人 全国公私病院連盟 (令和4年2月22日). https://www.byo-ren.com/pdf/r3gaiyou.pdf (2022.08.10 available)
 
P.46 掲載の参考文献
1) 令和3年 病院運営実態分析調査の概要 (令和3年6月調査) : 一般社団法人 全国公私病院連盟 (令和4年2月22日). https://www.byo-ren.com/pdf/r3gaiyou.pdf (2022.08.10 available)
 
P.50 掲載の参考文献
1) 田島誠一, 高橋淑郎 : 病院管理. 建帛社, 2012.
 
2) 第1回特定機能病院及び地域医療支援病院のあり方に関する検討会資料, 平成24年3月15日. https://www.mhlw.go.jp/stf/shingi/2r985200000253pd-att/2r985200000253tc.pdf (2022.11.10 available)
 
3) 西智弘,矢野和美,柏木秀行 : 緩和ケア 2021年6月増刊号 緩和ケアに活かすICT, 青海社
 
P.55 掲載の参考文献
1) 一般社団法人 日本病院会 : 2020年度 QIプロジェクト結果報告. https://www.hospital.or.jp/pdf/06_20211202_01.pdf (2022.06.20 available
 

第4章 患者満足

P.67 掲載の参考文献
1) 保健医療2035サイト https://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/shakaihoshou/hokeniryou2035/future/
 

第5章 報告・記録

P.73 掲載の参考文献
1) The Australian Council on Healthcare Standards (ACHS). AUSTRALASIAN CLINICAL INDICATOR REPORT 15th Edition 2006-2013. http://www.achs.org.au/media/88679/clinical_indicator_report_2006_2013.pdf (2017.06.24 available)
 
2) 公益財団法人 日本医療機能評価機構 : 病院機能評価データブック 2020年度, 2021年12月15日発行
 
3) 日本医療情報学会・日本診療情報管理学会 : 退院サマリー作成に関するガイダンス Sep 2019
 
P.74 掲載の参考文献
1) Matsumoto Y et al. : Evaluated Laboratory Information Technology for Quality Manager Our Clinical Laboratory. The 6th Cherry Blossom Symposium. International Conference of Clinical Laboratory Automation and Robotics, Kobe, Japan. April 18-19, P.79, 2008.
 
2) 佐々木良子, 他 : 検査室精度管理の定量評価について. 臨床病理. 54 : 168, 2006.
Medical*Online
3) Shikano H et al. : Evaluation of Renovated Laboratory Information System and Laboratory Automation System for Quality Management of Clinical Laboratory. The 10th Cherry Blossom Symposium. International Conference of Clinical Laboratory Automation, Seoul, Korea, April 20-22, P.53, 2016.
 
4) 田篠絵理香, 他 : 当院検体検査室の全面改装およびシステム更新による業務効果の評価-JCI認証の過程を含め-. 臨床病理. 66 : 24, 2018.
Medical*Online

第6章 看護

P.79 掲載の参考文献
1) 「看護ケアの質の評価基準に関する研究」 : 1993年文部科学研究, 主任研究者片田範子.
 
2) American Nurses Credentialing Center : Magnet Recognition Program, 2005.
 
3) The Australian Council on Healthcare Standards : ACHS Australasian Clinical Indicator Report : 2001-2008 Determining the Potential to Improve Quality of Care : 10th Edition. http://www.achs.org.au/pdf/temp/Australasian_Clinical_Indicator_Report_200108_10thEdition.pdf (2011.04.25 available)
 
4) 一般社団法人 日本病院会 : 2018年度 QIプロジェクト (QI推進事業) 結果報告. https://www.hospital.or.jp/pdf/06_20191120_01.pdf (2022.11.10 available)
 
5) The Joint Commission ; The Implementation Guide for the NQF Endorsed Nursing-Sensitive Care Measure Set 2009, version 2.0. http://www.jointcommission.org/assets/1/6/NSC%20Manual.pdf (2017.06.24 available)
 
6) European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel ; Pressure Ulcer Prevention : Quick Reference Guide. http://www.npuap.org/Final_Quick_Prevention_for_web_2010.pdf (2017.06.24 available)
 
7) 日本褥瘡学会編 : 褥瘡予防・管理ガイドライン 第5版. 照林社, 2022.3
 
P.82 掲載の参考文献
1) 日本褥瘡学会編 : 褥瘡予防・管理ガイドライン 第5版. 照林社, 2022.3
 
P.86 掲載の参考文献
1) Inouye SK, Westendorp RG, Saczynski JS : Delirium in elderly people. Lancet. 2014 ; 383 (9920) : 911-922.
PubMed
2) Huang J : 07-神経疾患, せん妄および認知症, せん妄, MDSマニュアル プロフェッショナル版, 2020. https://www.msdmanuals.com/ja-jp/ (2022.11.10 available)
 
3) 中村孝子, 綿貫成明 : せん妄を発症した患者に対する理解と回復へのケア-患者の記憶に基づいた体験内容とその影響に関する文献レビュー (1996-2007). 国立病院看護研究学会誌 2011 ; 7 (1) : 2-12.
 
4) 日本精神神経学会監訳 : 米国精神医学会治療ガイドライン せん妄. 医学書院, 2000.
 
P.90 掲載の参考文献
1) 厚生労働科学研究費補助金事業 (医療安全・医療技術評価総合研究事業) 平成16-18年度「医療安全のための教材と教育方法の開発に関する研究」班研究報告書 別冊「転倒・転落対策のガイドライン」 (主任研究者 : 上原鳴夫).
 
2) Healey F, Scobie S, Glampson B, Pryce A, Joule N, Willmott M : Slips, trips and falls in hospital. London : NHS 2007 ; 1.
 
3) Montalvo I : The National Database of Nursing Quality Indicators TM (NDNQI(R)). OJIN : The Online Journal of Issues in Nursing 2007 ; 12.
 
4) 一般社団法人日本病院会 : 2019年度QIプロジェクト結果報告 https://www.hospital.or.jp/pdf/06_20201201_01.pdf (2022.11.10 available)
 
5) Kruschke C, Butcher HK : Evidence-based practice guideline : Fall prevention for older adults. J Gerontol Nurs. 2017 ; 43 (11) : 15-21.
PubMed
P.93 掲載の参考文献
1) Healey F, Scobie S, Glampson B, Pryce A, Joule N, Willmott M : Slips, trips and falls in hospital. London : NHS. 2007 ; 1.
 
2) Callis N : Falls prevention : Identification of predictive fall risk factors. Appl Nurs Res. 2016 ; 29 : 53-58.
PubMed
P.95 掲載の参考文献
1) HBIPS-2 Hours of physical restraint use. Joint Commission National Quality Core Measures.
 
2) 厚生労働省「身体拘束ゼロ作戦推進会議」 : 身体拘束ゼロへの手引き, 2001. https://www.fukushihoken.metro.tokyo.lg.jp/zaishien/gyakutai/torikumi/doc/zero_tebiki.pdf (2022.11.10 available)
 
3) 日本看護倫理学会, 臨床倫理ガイドライン検討委員会 : 身体拘束予防ガイドライン, P3, 2015. http://jnea.net/pdf/guideline_shintai_2015.pdf (2022.11.10 available)
 
4) 日本老年看護学会 : 「急性期病院において認知症高齢者を擁護する」日本老年看護学会の立場表明 2016, P5, 2016.
 

第7章 検査・薬剤

P.99 掲載の参考文献
1) kirigaya D, Nakayama T, Ishizaki T, et al. : Management and treatment of osteoporosis in patients receiving long-term glucocorticoid treatment : current status of adherence to clinical guidelines and related factors. Intern Med. 2011 ; 50 (22) : 2793-2800.
PubMed
2) Majumdar SR, Lix LM, Yogendran M, et al. : Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008). J Clin Endocrinol Metab. 2012 ; 97 (4) : 1236-1242.
PubMed
3) 厚生統計協会編 : 厚生の指標臨時増刊 国民衛生の動向 2003年 第50巻 第9号. 厚生統計協会, 2003.
 
4) Ensrud KE, Thompson DE, Cauley JA, et al. : Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc. 2000 ; 48 (3) : 241-249.
 
5) Lu-Yao GL, Baron JA, Barrett JA, et al. : Treatment and survival among elderly Americans with hip fractures : a population-based study. Am J Public Health. 1994 ; 84 (8) : 1287-1291.
PubMed
6) Roux C, Seeman E, Eastell R, et al. : Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin. 2004 ; 20 (4) : 433-439.
 
7) Buckley Lenore, et al. 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-Induced osteoporosis. Arthritis & rheumatology, 2017. 69, (8) : 1521-1537.
PubMed
8) Suda M, et al. : Effects of quality indicator monitoring for glucocorticoid-induced osteoporosis and trends of drug treatment in a Japanese hospital. Int J Rheum Dis. 2018 ; 21 (5) : 975-981.
 
9) Confavreux CB, Canoui-Poitrine F, Schott AM, et al. : Persistence at 1 year of oral antiosteoporotic drugs : a prospective study in a comprehensive health insurance database. Eur J Endocrinol. 2012 ; 166 (4) : 735-741.
 
10) Dore RK, Cohen SB, Lane NE, et al. : Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates. Ann Rheum Dis. 2010 ; 69 (5) : 872-875.
PubMed
11) Saag KG, Zanchetta JR, Devogelaer JP, et al. : Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis : thirty-six-month results of a randomized, double-blind, controlled trial. Arthritis Rheum. 2009 ; 60 (11) : 3346-3355.
PubMed
P.102 掲載の参考文献
1) 恩田光子, 小林暁峯, 黒田和夫, 他 : 薬剤管理指導が患者アウトカムに与える効果に関する研究. 医療マネジメント学会雑誌. 医療マネジメント学会, 2004 ; 5 (2) : 349-353.
Medical*Online
2) 恩田光子, 小林暁峯, 黒田和夫, 他 : 薬剤管理指導業務が臨床アウトカムに与える影響に関する研究. 病院管理. 2004 ; 41 (4) : 255-262.
 
3) Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. : US pharmacists' effect as team members on patient care : systematic review and meta-analyses. Med Care. 2010 ; 48 (10) : 923-933.
PubMed
4) 木幡華子, 計良貴之, 田中恒明, 他 : 薬剤師の病棟配置が薬物療法の質および医療安全に与える影響. 日本病院薬剤師会雑誌. 2012 ; 48 (2) : 173-176.
Medical*Online
5) 日本病院薬剤師会総務部 : 平成30年度 病院薬剤部門の現状調査 集計結果報告. 日本病院薬剤師会雑誌. 2019 ; 55 (12) : 1373-1423.
 
P.104 掲載の参考文献
1) 稲田健, 石郷岡純 : シンプル処方のすすめ, 臨床精神医学. 2014 ; 43 (1) : 5-10.
Medical*Online
2) 橋本亮太, 安田由華, 藤本美智子, 山森英長 : 統合失調症における多剤・大量療法の功罪-ガイドラインから-. 精神神経学雑誌. 2017 ; 119 (3) : 185-191.
 
3) 河野敏明, 稲田健 : わが国の精神科治療薬の多剤・大量・長期処方の現状と課題. 薬局. 2018 ; 69 (9) : 2812-2816.
 
4) 中川敦夫, 他 : 向精神薬の処方実態に関する国内外の比較研究. 厚生労働科学特別研究事業, 2011.3
 
P.106 掲載の参考文献
1) Perrillo RP, Gish R, Falck-Ytter YT : American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology. 2015 ; 148 (1) : 221-244.e3.
 
2) Torres HA, Davila M : Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol. 2012 ; 9 (3) : 156-166.
PubMed
3) Ramsey SD, Unger J, Baker LH, et al, : Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices. JAMA Oncol. 2019 ; 5 (4) : 497-505.
PubMed
4) 日本肝臓学会, 肝炎診療ガイドライン作成委員会編 : B型肝炎治療ガイドライン (第3.4版). 2021.5 https://www.jsh.or.jp/lib/files/medical/guidelines/jsh_guidlines/B_v3.4.pdf (2022.11.10 available)
 

第8章 手術・処置

P.111 掲載の参考文献
1) Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ : The impact of surgical-site infections in the 1990s : attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999 ; 20 : 725-730.
PubMed
2) CDC : Guideline for the Prevention of Surgical Site Infection, 1999. Infect Cont Hosp Epidemiol 1999 ; 20 : 247-278.
 
3) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a SCIP-Inf-1 Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision. http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015.06.04 available)
 
4) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
5) 一般社団法人 日本病院会 : 2021年度 QIプロジェクト結果報告. https://www.hospital.or.jp/pdf/06_20221023_01.pdf (2022.10.25 available)
 
P.112 掲載の参考文献
1) Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ : The impact of surgical-site infections in the 1990s : attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999 ; 20 : 725-730.
PubMed
2) CDC : Guideline for the Prevention of Surgical Site Infection, 1999. Infect Cont Hosp Epidemiol 1999 ; 20 : 247-278.
 
3) The Joint Commission : Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a SCIP-Inf-2 Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision. http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015.06.04 available)
 
4) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
5) 一般社団法人 日本病院会 : 2021年度 QIプロジェクト結果報告. https://www.hospital.or.jp/pdf/06_20221023_01.pdf (2022.10.25 available
 
P.114 掲載の参考文献
1) Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ : The impact of surgical-site infections in the 1990s : attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999 ; 20 (11) : 725-730.
PubMed
2) CDC : Guideline for the Prevention of Surgical Site Infection, 1999. Infect Cont Hosp Epidemiol. 1999 ; 20 : 247-278.
 
3) Bratzler DW, Houck PM : Antimicrobial prophylaxis for surgery : an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004 ; 38 (12) : 1706-1715.
PubMed
4) Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR : The Society of Thoracic Surgeons Practice Guideline Series : Antibiotic Prophylaxis in Cardiac Surgery, Part I : Duration. Ann Thorac Surg. 2006 ; 81 (1) : 397-404.
 
5) The Joint Commission : Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a SCIP-Inf-3 Prophylactic Antibiotic Discontinued Within 24 Hours After Surgery End Time (48 hours for CABG or Other Cardiac Surgery) http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015.06.04 available)
 
6) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
7) 一般社団法人 日本病院会 : 2021年度 QIプロジェクト結果報告. https://www.hospital.or.jp/pdf/06_20221023_01.pdf (2022.10.25 available
 
P.115 掲載の参考文献
1) National Institute for Health and Care Excellence : The management of hip fracture in adults. clinical guideline 2011 Jun, updated 2017 May.
 
2) Kristensen PK, Thillemann TM, Soballe K, Johnsen SP : Are process performance measures associated with clinical outcomes among patients with hip fractures? A population-based cohort study. Int J Qual Health Care. 2016 ; 28 (6) : 698-708.
PubMed
3) Kamel HK, Iqbal MA, Mogallapu R, Maas D, Hoffmann RG : Time to ambulation after hip fracture surgery : relation to hospitalization outcomes. J Gerontol A Biol Sci Med Sci. 2003 ; 58 (11) : 1042-1045.
PubMed
P.118 掲載の参考文献
1) 黒瀧健二, 齋藤浩二 : シバリングはなぜ起こるのか, 周術期の体温調節性反応の機序, LiSA. 2014 ; 21 (9)
 
2) Ciofolo MJ, Clergue F, Devilliers C, et al. Changes in ventilation, oxygen uptake, and carbon dioxide output during recovery from isoflurane anesthesia. Anesthesiology. 1989 ; 70 : 737-741.
PubMed
3) Reymond CA. Anesthesia sends shivers up one's spine, but hypothermia per se may not be culprit. JAMA. 1988 ; 259 : 2646-2647.
 
4) Mahajan RP, Grover VK, Sharma SL, et al. : Intraocular pressure changes during muscular hyperactivity after general. anesthesia. Anesthesiology 1987 ; 66 : 419-421.
PubMed
5) De Courcy JG : Artefactual 'hypotension' from shivering. Anesthesia. 1989 ; 44 (9) : 787-788.
PubMed
6) 山蔭道明編 : 周術期の体温管理, 克誠堂出版, 2011.
 
7) 山蔭道明監修 : 体温のバイオロジー 体温はなぜ37℃なのか. メディカル・サイエンス・インターナショナル, 2005.
 
P.120 掲載の参考文献
1) SuLu E, et al. : Delays in the diagnosis and treatment of non-small-cell lung cancer. Tumori. 2011 ; 97 (6) : 693-697.
PubMed
2) Myrdal G, et al. : Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax. 2004 ; 59 (1) : 45-49.
PubMed
3) Salomaa ER, et al. : Delays in the diagnosis and treatment of lung cancer. Chest. 2005 ; 128 (4) : 2282-2288.
PubMed
4) Kanarek NF, et al. : Survival after community diagnosis of early-stage non-small cell lung cancer. Am J Med. 2014 ; 127 (5) : 443-449.
PubMed
5) Samson P, et al. : Effects of Delayed Surgical Resection on Short-Term and Long-Term outcomes in Clinical Stage I Non-Small Cell Lung Cancer. Ann Thorac Surg. 2015 ; 99 (6) : 1906-1913.
 
6) Heiden BT et al. : Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer. JAMA Network Open.2021 ; 4 (5) : e2111613.
 
7) British Thoracic Society : BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. Thorax. 1998 ; 53 (Suppl 1) : S1-8.
PubMed
8) Simunovic M, et al. : A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario. Can Med Assoc J,. 2001 ; 165 (4) : 421-425.
 

第9章 生活習慣

P.125 掲載の参考文献
1) 日本糖尿病学会編著 : 糖尿病診療ガイドライン 2019. 南江堂, 2019.
 
2) 日本糖尿病・生活習慣病ヒューマンデータ学会 糖尿病標準診療マニュアル作成委員会 : 糖尿病標準診療マニュアル 2022 一般診療所・クリニック向け. 日本糖尿病・生活習慣病ヒューマンデータ学会, 2022.
 
3) 日本糖尿病学会と日本老年医学会の合同委員会 : 高齢者糖尿病の血糖コントロール目標 2016.
 
P.126 掲載の参考文献
1) Criteria, P. S. : HYPERTENSION (HTN) Algorithm for Measures Calculation-EHRS (Analytic Narrative and Data Elements) PATIENT SELECTION CRITERIA Include if ALL the following criteria are met : At least two face-to-face office visits with the physician, physicians' assistant, or nurse practitioner during the measurement time period Is aged 18 years and older at the beginning of the measurement time period Patient has a documented diagnosis of Hypertension. Blood Pressure 2006 : 1-12.
 
2) Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. : Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 ; 42 (6) : 1206-1252.
PubMed
3) American Medical Association. HYPERTENSION (HTN) Algorithm for Measures calculation-EHRS (Analytic Narrative and Data Elements). http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/htnanalyticnarr307_7.pdf (2014.06.24 avaliable)
 
4) NICE Menu of Indicators. The percentage of patients under 80 years old with hypertension in whom the last recorded blood pressure (measured in the preceding 9 months) is 140/90 or less. http://www.nice.org.uk/aboutnice/qof/indicators.jsp (2014.06.24 available)
 
P.129 掲載の参考文献
1) Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P : Heart disease and stroke statistics-2006 update : a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006 ; 113 (6) : e85-151.
PubMed
2) Psaty BM, Manolio TA, Smith NL, Heckbert SR, Gottdiener JS, Burke GL, et al. : Time trends in high blood pressure control and the use of antihypertensive medications in older adults : the Cardiovascular Health Study. Arch Intern Med. 2002 ; 162 (20) : 2325-2332.
PubMed
3) Turnbull F : Effects of different blood-pressure-lowering regimens on major cardiovascular events : results of prospectively-designed overviews of randomised trials. Lancet. 2003 ; 362 (9395) : 1527-1535.
PubMed
4) Blood Pressure Lowering Treatment Trialists' Collaboration, Turnbull F, Neal B, Pfeffer M, Kostis J, Algert C, Woodward M, et al. : Blood pressuredependent and independent effects of agents that inhibit the reninangiotensin system. J Hypertens. 2007 ; 25 (5) : 951-958.
PubMed
5) James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E : 2014 evidence-based guideline for the management of high blood pressure in adults : report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 ; 311 (5) : 507-520.
 
6) 日本高血圧学会高血圧治療ガイドライン作成委員会編 : 高血圧治療ガイドライン 2019. 日本高血圧学会, 2019.
 
7) Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. : Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine : the VALUE randomized trial. Lancet. 2004 ; 363 (9426) : 2022-2031.
PubMed
8) NHS Employers : Quality and Outcomes Framework guidance for GMS contract 2011/12-Delivering investment in general practice. April 2011. http://www.nhsemployers.org/Aboutus/Publications/Documents/QOF_guidance_GMS_contract_2011_12.pdf (2014.06.24 available)
 
9) SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, et al. : A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015 ; 373 (22) : 2103-2116.
 
10) Phillips LS, Branch WT, Cook CB, et al. : Clinical inertia. Ann Intern Med. 2001 ; 135 (9) : 825-834.
PubMed
11) Lewington S, Clarke R, Qizilbash N, et al. : Age-specific relevance of usual blood pressure to vascular mortality : a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002 ; 360 (9349) : 1903-1913.
PubMed
12) Delgado J, Bowman K, Ble A, et al. : Blood Pressure Trajectories in the 20 Years Before Death. JAMA Intern Med. 2018 ; 178 (1) : 93-99.
PubMed

第10章 脳・神経

P.133 掲載の参考文献
1) Berkhemer OA et al. : A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015 ; 372 (1) : 11-20.
PubMed
P.135 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a STK-2 Discharged on Antithrombotic Therapy. http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015.06.04 available)
 
3) 日本脳卒中学会 脳卒中ガイドライン委員会編 : 脳卒中治療ガイドライン 2015. 協和企画, 2017.
 
4) 日本脳卒中学会 脳卒中ガイドライン委員会編 : 脳卒中治療ガイドライン 2021. 協和企画, 2021.
 
P.137 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a STK-3 Anticoagulation therapy for atrial fibrillation/flutter. http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015.06.04 available)
 
3) 日本脳卒中学会 脳卒中ガイドライン委員会編 : 脳卒中治療ガイドライン 2015. 協和企画, 2017.
 
4) 日本脳卒中学会 脳卒中ガイドライン委員会編 : 脳卒中治療ガイドライン 2021. 協和企画, 2021.
 
P.139 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a STK-10 Assessed for Rehabilitation. http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015.06.04 available)
 
3) 日本脳卒中学会 脳卒中ガイドライン委員会編 : 脳卒中治療ガイドライン 2015. 協和企画, 2017.
 
4) 日本脳卒中学会 脳卒中ガイドライン委員会編 : 脳卒中治療ガイドライン 2021. 協和企画, 2021.
 

第11章 心血管

P.143 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) The Joint Commission : Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b AMI-8a Primary PCI Received Within 90 Minutes of Hospital Arrival. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015.06.04 available)
 
3) Antman EM, et al. : ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Circulation. 2004 ; 110 (9) : e82-292.
PubMed
4) Flynn A, et al. : Trends in door-to-balloon time and mortality in patients with STEMI undergoing PPCI. Arch Intern Med. 2010 ; 170 : 1842-1849.
 
5) 日本心血管インターベンション治療学会 (CVIT) : J-PCIレジストリー 2018年報告. http://www.cvit.jp/registry/annual-report.html (2022.11.10 available)
 
P.146 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b AMI-1 Aspirin at Arrival. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015.06.04 available)
 
P.148 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) The Joint Commission : Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b AMI-3 ACEI or ARB for LVSD. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015.06.04 available)
 
3) Krumholz HM, et al. : ACC/AHA clinical performance measures for adults with ST-elevation and non ST-elevation myocardial infarction. Circulation. 2006 ; 113 (5) : 732-761.
PubMed
P.151 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) 日本循環器学会 他 : 急性冠症候群診療ガイドライン (2018年改訂版) https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2018_kimura.pdf (2022.11.10 available)
 
3) 日本循環器学会 他 : 2020年 JCSガイドライン フォーカスアップデート版 冠動脈疾患患者における抗血栓療法 https://www.j-circ.or.jp/cms/wp-content/uploads/2020/04/JCS2020_Kimura_Nakamura.pdf (2022.11.10 available)
 
4) Foresi A, Cavigioli G, Signorelli G, Pozzoni MB, Olivieri D : Is the use of beta-blockers in COPD still an unresolved dilemma?. Respiration ; international review of thoracic diseases 2010 ; 80 (3) : 177-187.
PubMed
5) The Joint Commission : Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b AMI-2 Aspirin Prescribed at Discharge. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015.06.04 available)
 
6) The Joint Commission : Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b AMI-5 Beta-Blocker Prescribed at Discharge. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015.06.04 available)
 
7) The Joint Commission : Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b AMI-10 Statin Prescribed at Discharge. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015.06.04 available)
 
8) Hector MM, Christopher PC, Xin Z, et al. : Quality of acute myocardial infarction care and outcomes in 33, 997 patients aged 80 years or older : Findings from Get With The Guidelines-Coronary Artery Disease (GWTG-CAD). Am Heart j. 2011 ; 162 (2) : 283-290.
PubMed
P.152 掲載の参考文献
1) Agency for Healthcare Research and Quality : INPATIENT QUALITY INDICATORS (IQI) BENCHMARK DATA TABLES, v2021. https://qualityindicators.ahrq.gov/Downloads/Modules/IQI/V2021/Version_2021_Benchmark_Tables_IQI.pdf (2022.06.20 available)
 
2) Agency for Healthcare Research and Quality : Inpatient quality indicator 30 (IQI30) percutaneous coronary intervention (PCI) mortality rate https://www.qualityindicators.ahrq.gov/Downloads/Modules/IQI/V2021/TechSpecs/IQI_30_Percutaneous_Coronary_Intervention_(PCI)_Mortality_Rate.pdf (2022.06.20 available)
 
P.154 掲載の参考文献
1) The Joint Commission : Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b HF-2 Evaluation of LVS Function. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015.06.04 available)
 
2) Bonow RO, Ganiats TG, Beam CT, et al. : ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation. 2012 ; 125 (19) : 2382-2401.
 
3) Paul A. et al :. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure : A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 ; 145 : e895-e1032.
 
4) 日本循環器学会, 日本心不全学会合同ガイドライン : 急性・慢性心不全診療ガイドライン (2017年改訂版) https://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h.pdf (2022.09.29 available)
 
5) 日本循環器学会, 日本心不全学会合同ガイドライン : 2021年 JCS/JHFSガイドラインフォーカスアップデート版 急性・慢性心不全診療 https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Tsutsui.pdf (2022.09.29 available)
 
P.156 掲載の参考文献
1) American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) /Physician Consortium for Performance Improvement(R) (PCPI(TM)), Heart Failure Performance Measurement Set, ACCF/AHA Approved December 2010, PCPI Approved January 2011, Updated May 15, 2012. http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/hfset-12-5.pdf (2014.07.07 available)
 
2) The Joint Commission : Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b HF-3 ACEI or ARB for LVSD. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015.06.04 available)
 
3) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
4) Yancy CW, et al. : 2013 ACCF/AHA guideline for the management of heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 ; 128 (16) : e240-327.
 
5) Virani SS, Alonso A, Benjamin EJ, et al. : Heart Disease and Stroke Statistics-2020 Update : A Report From the American Heart Association, Circulation. 2020 ; 141 (9) : e139-e596. (Unpublished American Heart Association tabulation, GWTG-HF, July 1, 2017, to June 30, 2018.)
 
6) Paul A. et al. : 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure : A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 ; 145 : e895-e1032.
 
7) 日本循環器学会, 日本心不全学会合同ガイドライン : 急性・慢性心不全診療ガイドライン (2017年改訂版) https://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h.pdf (2022.09.29 available)
 
8) 日本循環器学会, 日本心不全学会合同ガイドライン : 2021年 JCS/JHFSガイドラインフォーカスアップデート版 急性・慢性心不全診療 https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Tsutsui.pdf (2022.09.29 available)
 
P.160 掲載の参考文献
1) American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) /Physician Consortium for Performance Improvement(R) (PCPI(TM)), Heart Failure Performance Measurement Set, ACCF/AHA Approved December 2010, PCPI Approved January 2011, Updated May 15, 2012. http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/hfset-12-5.pdf (2014.07.07 available)
 
2) Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ, Grady KL, Hundley RF, Jessup M, Lynn TE, Masoudi FA, Nilasena D, Pina IL, Rockswold PD, Sadwin LB, Sikkema JD, Sincak CA, Spertus J, Torcson PJ, Torres E, Williams MV, Wong JB : ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation. 2012 ; 125 (19) : 2382-2401.
 
3) Yancy CW, et al. : 2013 ACCF/AHA guideline for the management of heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 ; 128 (16) : e240-327.
 
P.161 掲載の参考文献
1) The Joint Commission : Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b HF-1 Discharge Instructions. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015.06.04 available)
 
2) Bonow RO, Ganiats TG, Beam CT, et al. : ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation. 2012 ; 125 (19) : 2382-2401.
 
3) Yancy CW, et al. : 2013 ACCF/AHA guideline for the management of heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation.2013 ; 128 (16) : e240-327.
 
4) VanSuch M, Naessens JM, Stroebel RJ, Huddleston JM, Williams AR. : Effect of discharge instructions on readmission of hospitalised patients with heart failure : do all of the Joint Commission on Accreditation of Healthcare Organizations heart failure core measures reflect better care?. Qual Saf Health Care. 2006 ; 15 (6), 414-417.
PubMed

第12章 感染管理

P.165 掲載の参考文献
1) 日本環境感染学会JHAIS委員会 医療器具関連感染サーベイランス 2019年1月～2021年12月データサマリー http://www.kankyokansen.org/uploads/uploads/files/jsipc/jhais_device-summary2021.12.pdf (2022.07.03 available)
 
2) Centers for Disease Control and Prevention : Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5110a1.htm (2022.07.03 available)
 
3) Umscheid CA, Mitchell MD, Doshi JA, et al. : Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011 ; 32 (2) : 101-114.
 
4) Buetti N, Marschall J, Drees M, et al. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals : 2022 Update. Infect Control Hosp Epidemiol. 2022 ; 43 (5) ; 1-17.
 
P.166 掲載の参考文献
1) 日本環境感染学会JHAIS委員会 医療器具関連感染サーベイランス 2019年1月～2021年12月データサマリー http://www.kankyokansen.org/uploads/uploads/files/jsipc/jhais_device-summary2021.12.pdf (2022.09.02 available)
 
2) Saint S, Chenoweth CE : Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am. 2003 ; 17 (2) : 411-432.
PubMed
3) Rutala WA, et al. : Incidence of catheter-associated and non-catheter-associated urinary tract infections in a healthcare system. Infect Control Hosp Epidemiol. 2011 ; 32 (8) : 822-823.
 
4) Warren JW, Platt R, Thomas RJ, et al. : Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med. 1978 ; 299 (11) : 570-573.
PubMed
5) Haley RW, Hooton TM, Culver DH, et al. : Nosocomial infections in U.S. hospitals, 1975-1976 : estimated frequency by selected characteristics of patients. Am J Med. 1981 ; 70 (4) : 947-959.
PubMed
6) Tambyah PA, Maki DG : Catheter-associated urinary tract infection is rarely symptomatic : a prospective study of 1,497 catheterized patients. Arch Intern Med. 2000 ; 160 (5) : 678-682.
PubMed
7) Saint S : Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control. 2000 ; 28 (1) : 68-75.
PubMed
8) Leuck AM, Wright D, Ellingson L, et al. : Complications of Foley catheters--is infection the greatest risk?. J Urol. 2012 ; 187 (5) : 1662-1666.
 
9) Umscheid CA, Mitchell MD, Doshi JA, et al. : Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011 ; 32 (2) : 101-114.
 
10) Agency for Healthcare Research and Quality : Appendix K. Infographic Poster on CAUTI Prevention. Content last reviewed October 2015. http://www.ahrq.gov/professionals/quality-patient-safety/hais/cauti-tools/impl-guide/implementation-guide-appendix-k.html (2022.07.03 available)
 
11) Jain P, Parada JP, David A, et al. : Overuse of the indwelling urinary tract catheter in hospitalized medical patients. Arch Intern Med. 1995 ; 155 (13) : 1425-1429.
PubMed
12) Saint S, Wiese J, Amory JK, et al. : Are physicians aware of which of their patients have indwelling urinary catheters? Am J Med. 2000 ; 109 (6) : 476-480.
PubMed
P.169 掲載の参考文献
1) Safdar N, Dezfulian C, Collard HR, et al. : Clinical and economic consequences of ventilator-associated pneumonia : a systematic review. Crit Care Med. 2005 ; 33 (10) : 2184-2193.
PubMed
2) 日本環境感染学会JHAIS委員会 医療器具関連感染サーベイランス 2019年1月～2021年12月データサマリー VAE (VAC. IVAC. PVAP). http://www.kankyokansen.org/uploads/uploads/files/jsipc/jhais_device-summary2021.12.pdf (2022.09.05 available)
 
3) 日本集中治療医学会 ICU機能評価委員会 : 人工呼吸関連肺炎予防バンドル 2010改訂版 (略 : VAPバンドル). http://www.jsicm.org/pdf/2010VAP.pdf (2022.09.05 available)
 
4) 日本集中治療医学会, 日本呼吸療法医学会, 日本クリティカルケア看護学会 : 人工呼吸器離脱に関する 3学会合同プロトコル. 2015. https://www.jsicm.org/pdf/kokyuki_ridatsu1503b.pdf (2022.09.05 available)
 
5) 日本クリティカルケア看護学会 口腔ケア委員会 : 気管挿管患者の口腔ケア実践ガイド. 2021. https://www.jaccn.jp/guide/pdf/OralCareGuide_202102.pdf (2022.09.05 available)
 
P.171 掲載の参考文献
1) Cosgrove SE, Sakoulas G, Perencevich EN, et al. : Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia : a meta-analysis. Clin Infect Dis. 2003 ; 36 (1) : 53-59.
PubMed
2) Cosgrove SE, Qi Y, Kaye KS, et al. : The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes : mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005 ; 26 (2) : 166-174.
PubMed
3) Nelson RE, Slayton RB, Stevens VW, et al. : Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus. Infect Control Hosp Epidemiol. 2017 ; 38 (7) : 848-856.
PubMed
4) Calfee DP, Salgado CD, Milstone AM, et al. : Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals : 2014 update. Infect Control Hosp Epidemiol. 2014 ; 35 (7) : 772-796.
PubMed
P.172 掲載の参考文献
1) National Healthcare Safety Network (NHSN) : Multidrug-Resistant Organism & Clostridioides difficile infection (MDRO/CDI) Module. 2022. https://www.cdc.gov/nhsn/pdfs/pscmanual/12pscmdro_cdadcurrent.pdf (2022.06.24 available)
 
2) McDonald LC, Gerding DN, Johnson S, et al. : Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children : 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 ; 66 (7) : e1-e48. https://www.idsociety.org/practice-guideline/clostridium-difficile/ (2022.06.24 available)
 
P.174 掲載の参考文献
1) Centers for Disease Control and Prevention : Guideline for Hand Hygiene in Health-Care Settings, 2002. MMWR 2002 ; 51 : RR-16. http://www.cdc.gov/handhygiene/guidelines.html (2022.06.24 available)
 
2) WHO : WHO Guidelines on Hand Hygiene in Health Care. 2009. http://www.who.int/publications/i/item/9789241597906 (2022.06.24 available)
 
3) Zingg W, Holmes A, Dettenkofer M, et al. : Hospital organisation, management, and structure for prevention of health-care-associated infection : a systematic review and expert consensus. Lancet Infect Dis. 2015 ; 15 (2) : 212-224.
PubMed
P.178 掲載の参考文献
1) Consensus paper on the surveillance of surgical wound infections. The Society for Hospital Epidemiology of America, The Association for Practitioners in Infection Control, The Centers for Disease Control, The Surgical Infection Society. Infect Control Hosp Epidemiol. 1992 ; 13 (10) : 599-605.
 
2) Boyce JM, Potter-Bynoe G, Dziobek L : Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol. 1990 ; 11 (2) : 89-93.
PubMed
3) Poulsen KB, Bremmelgaard A, Sorensen AI, et al. : Estimated costs of postoperative wound infections. A case-control study of marginal hospital and social security costs. Epidemiol Infect. 1994 ; 113 (2) : 283-295.
PubMed
4) Umscheid CA, Mitchell MD, Doshi JA, et al. : Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011 ; 32 (2) : 101-114.
 
5) Allegranzi B, Bischoff P, de Jonge S, et al. : New WHO recommendations on preoperative measures for surgical site infection prevention : an evidencebased global perspective. Lancet Infect Dis. 2016 ; 16 (12) : e276-287.
PubMed
6) Berrios-Torres SI, Umscheid CA, Bratzler DW, et al. : Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017 ; 152 (8) : 784-791.
PubMed
7) Ban KA, Minei JP, Laronga C, et al. : American College of Surgeons and Surgical Infection Society : Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2017 ; 224 (1) : 59-74.
 
8) 厚生労働省 院内感染対策サーベイランス事業SSI部門 公開情報 2021年年報 https://janis.mhlw.go.jp/report/ssi.html (2022.07.01 available)
 

書評

最近チェックした商品履歴

Loading...